Integrated multi-omics reveals Enterococcus faecalis JM263 alleviates high-concentrate diet-induced hepatic injury via the gut-liver axis in goats Authors: Xinhong Zhou, Ammara Khan, Wenjie Xiang, Xiaoyun Shen Published: 2026 ABSTRACT AbstractBackgroundIn intensive ruminant production, long-term high-concentrate diets (HCD) are employed to increase short-term growth but frequently cause systemic inflammation, oxidative stress, and multiorgan damage, posing significant challenges to the sustainability of the goat industry. This study investigated the potential regulatory mechanisms of Enterococcus faecalis JM263, a strain isolated from yak gut contents, in mitigating HCD-induced inflammation and oxidative stress via the gut–liver axis. Twenty-four male Yudong black goats were randomly assigned to four groups: a control group (CON) and three treatment groups supplemented with 0.1, 0.5, or 1.0 g/kg E. faecalis JM263 (HCD1, HCD2, and HCD3, respectively) for 60 days.ResultsE. faecalis JM263 supplementation significantly attenuated intestinal and hepatic injury caused by systemic inflammation and oxidative stress, thereby enhancing growth performance and immune function. Mechanistically, E. faecalis JM263 mitigated systemic inflammation by reinforcing intestinal barrier function and remodeling the gut microbiota, which was associated with increased relative abundances of Muribaculaceae and Acetatifactor. Furthermore, E. faecalis JM263 reduced hepatic oxidative stress, accompanied by coordinated changes in the Nrf2/Keap1 signaling pathway and antioxidant enzyme activity. Integrated proteomics and metabolomics analyses revealed that E. faecalis JM263 was associated with changes in hepatic inflammatory responses and apoptosis, potentially through the regulation of arachidonic acid metabolism. Correlation analysis further showed close associations among the gut microbiota, arachidonic acid-related proteins/metabolites, and host phenotypic indices.ConclusionsIn summary, E. faecalis JM263 alleviates HCD-induced multiorgan damage and functional dysfunction by synergistically improving the intestinal barrier, suppressing systemic inflammation, and reducing oxidative stress. These findings highlight the efficacy of E. faecalis JM263 in promoting growth performance and maintaining health in ruminants via the gut–liver axis. Video AbstractGraphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s40168-026-02435-4.Keywords: High-concentrate diet, Enterococcus faecalis JM263, Goat, Nrf2/Keap1, Arachidonic acid metabolism Introduction In intensive ruminant production systems, high-concentrate diets (HCD) are widely employed to maximize growth performance and feed efficiency [1]. In many goat-farming regions of China, feeding strategies rely heavily on concentrate-rich rations, with concentrate inclusion rates reaching up to 90%. However, long-term provision of such diets can induce a series of gastrointestinal disorders that severely compromise animal health and meat quality. Previous studies have shown that rapid fermentation of high-concentrate feed in the rumen generates excessive organic acids, leading to a sharp decline in ruminal pH and subsequent rumen acidosis. This condition may also trigger ruminal tympany, causing abdominal pain, dyspnea, and other clinical symptoms in sheep [2]. Additionally, HCD profoundly alters the rumen microbiota, disrupts mucosal barrier integrity, and exposes the liver to inflammatory and oxidative insults originating from the gut, resulting in hepatocyte apoptosis, dysregulated lipid metabolism, and elevated inflammatory cytokines [3, 4]. Therefore, identifying novel strategies to improve gut–liver health through targeted modulation of the gut microbiota is essential for promoting sustainable and healthy ruminant production. The intestinal microbiota contains a gene repertoire approximately 100 times larger than that of the host genome and plays pivotal roles in maintaining health and regulating disease processes [5]. The gut and liver are closely connected through a complex and bidirectional communication system, within which gut microorganisms serve as key mediators [6]. As part of host metabolism, the intestinal ecosystem regulates multiple physiological functions. Microbial metabolites produced in the gut enter the portal vein and are subsequently absorbed by hepatocytes, making the liver the first organ exposed to nutrients and microbiota-derived molecules absorbed from the intestine [7]. Growing evidence has demonstrated that the gut–liver axis is central to linking diet, microbial ecology, and hepatic metabolic health [8]. As a critical bidirectional regulatory network, the gut–liver axis allows the gut microbiota and its metabolites to influence hepatic immune homeostasis, metabolic regulation, and inflammatory responses. Conversely, disturbances in this axis can induce hepatic oxidative stress, inflammatory injury, apoptosis, and metabolic reprogramming [9]. Over the past few decades, probiotics have garnered substantial attention because of their multifaceted functions in improving gut microecology, strengthening the intestinal barrier, and modulating immune and metabolic processes [10]. Numerous studies have demonstrated that probiotics can influence hepatic metabolism, immunity, and oxidative stress by reshaping the gut microbial composition and altering microbiota-derived metabolites [11, 12]. However, despite emerging evidence supporting the protective effects of probiotics on the gut–liver axis, systematic multiomics investigations are still lacking regarding how probiotics coordinate gut microbial shifts and mediate hepatic metabolic reprogramming under HCD-induced stress in ruminants. Moreover, commonly used commercial probiotic strains may not exhibit ideal efficacy in modulating the physiological imbalances associated with HCD feeding in ruminants. In our previous studies, we isolated a strain of E. faecalis JM263 from the intestinal contents of yaks inhabiting the Qinghai–Tibet Plateau and systematically evaluated its probiotic properties in vitro, demonstrating its strong potential as a feed additive [13]. Nevertheless, the in vivo effects of E. faecalis JM263 in ruminants remain unverified, particularly in the context of intensive production systems where animals are exposed to HCD-induced stress. Therefore, in the present study, we supplemented HCD-fed goats with different dosages of E. faecalis JM263 to investigate its impacts on growth performance, immunity, and overall health. Additionally, multiomics approaches, including microbiomics, metabolomics, and proteomics, were employed to explore the potential regulatory mechanisms of E. faecalis JM263 in alleviating systemic inflammatory responses and oxidative stress along the gut–liver axis. The findings of this study contribute to a deeper understanding of how E. faecalis JM263 supports intestinal and hepatic health and provide theoretical support for its application as a functional probiotic in ruminant production. Materials and methods Preparation of E. faecalis JM263 powder E. faecalis JM263 was previously isolated from the intestinal contents of yaks inhabiting the Qinghai–Tibet Plateau, and its probiotic properties have been systematically evaluated in vitro [13]. The strain was first inoculated into MRS broth and incubated at 37 °C with shaking at 180 r/min for 18 h to obtain the seed culture. Subsequently, 5% (v/v) of the seed culture was transferred into a 10 L fermenter containing MRS broth and incubated at 37 °C and 150 r/min for 16–18 h. The culture was subsequently centrifuged at 4 °C and 8000 r/min for 15 min to collect the bacterial pellet, which was washed twice with sterile saline and resuspended to form a bacterial paste. Maltodextrin was weighed to constitute 35% of the final lyophilized powder mass and was dissolved in 1.5-fold sterile water via water-bath heating and stirring. After sterilization at 115 °C for 15 min, the mixture was cooled to 37 °C. Under a laminar-flow hood, the bacterial paste was slowly mixed with the maltodextrin solution at an appropriate ratio and poured into sterile lyophilization trays. The trays were placed in a freeze-dryer for prefreezing at − 50 °C for 2–3 h, followed by sublimation drying at ≤ 10 Pa and − 50 °C for 12–16 h. The temperature was then raised to 25 °C for analytical drying for 4–6 h. After lyophilization, the chamber was gradually returned to atmospheric pressure, and the dried product was sieved through an 80-mesh sterile screen to obtain a uniform powder. The final product contained ≥ 1 × 109 CFU/g viable bacteria. To ensure dosing consistency during the feeding trial, the freeze-dried powder was prepared in batches every 7 days and was stored at 4 °C until use. Animals and diets Twenty-four 4-month-old healthy male Yudong black goats (initial body weight: 17.25 ± 0.49 kg) were randomly divided into four groups (n = 6). All groups were fed the same high-concentrate diet (roughage:concentrate = 20:80). Specifically, the CON group served as the high-concentrate diet challenge model group without E. faecalis JM263 supplementation, whereas the HCD1, HCD2, and HCD3 groups were supplemented with 0.1, 0.5, and 1 g/kg E. faecalis JM263 powder, respectively. The composition and nutrient levels of the basal diet are shown in Table S1. The goats were individually housed in pens equipped with feed troughs and water buckets. The animals were fed twice daily at 08:00 and 17:00 and had ad libitum access to water and natural light. The experimental period included a 10-day adaptation phase followed by a 60-day feeding trial. Sample collection At the end of the trial, 5 mL of blood was collected via jugular venipuncture into vacuum tubes. The samples were allowed to clot and then centrifuged at 3000×g for 10 min at 4 °C to separate the serum, which was stored at − 20 °C for biochemical analysis. The goats were subsequently euthanized via electrical stunning followed by exsanguination. The jejunum, jejunal contents, and liver tissues were rapidly collected, flash-frozen in liquid nitrogen, and stored at − 80 °C for subsequent omics analysis. Additionally, approximately 2 cm of jejunal tissue and 1 cm3 of liver tissue were fixed in 4% paraformaldehyde for histopathological examination. Measurements and methods Growth performance The initial body weight was measured before the start of the formal trial, and the final body weight was recorded on day 60 prior to the morning feeding. The average daily gain (ADG), average daily feed intake (ADFI), and feed conversion ratio (FCR) were calculated. The daily feed offered was recorded, and orts were collected before morning feeding, dried, and weighed. Serum and tissue biochemical analysis Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations were measured using an automated biochemical analyzer (Chemray 800; Rayto Life Science, China). Antioxidant indices, including superoxide dismutase (SOD), catalase (CAT), total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA), were analyzed using a microplate reader and a spectrophotometer. The levels of immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG), as well as cytokines including interleukin-1β (IL-1β), interleukin-2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10), were quantified using ELISA kits (Nanjing Jiancheng Bioengineering Institute, China). Serum and liver lipopolysaccharide (LPS) levels were measured using a commercial ELISA kit (SEB526Ge, Cloud-Clone Corp., USA) according to the manufacturer’s protocols. Histopathology of jejunum and liver Jejunum and liver tissues fixed in 4% paraformaldehyde were processed for trimming, dehydration, embedding, sectioning, staining, and mounting. The sections were examined via a Nikon Eclipse Ci-L microscope (Nikon, Japan). Images were captured at × 20 magnification, ensuring uniform lighting and full-field tissue coverage. For each jejunal sample, at least 8 well-oriented and intact villi and their associated crypts were selected for measurement. Villus height and crypt depth were measured using Image-Pro Plus 6.0 (Media Cybernetics, USA). TUNEL staining of jejunum and liver Paraffin sections of the jejunum and liver were dewaxed with xylene and ethanol. Antigen retrieval was performed with proteinase K at 37 °C for 20 min. After permeabilization for 20 min, TUNEL staining was conducted via a commercial kit (Servicebio, G1504). The sections were incubated in a humid chamber at 37 °C for 2 h, followed by DAPI counterstaining for 10 min. The slides were mounted with antifade medium and examined via a fluorescence microscope (Nikon Eclipse C1). Immunofluorescence staining of jejunum To assess the localization of the tight junction proteins ZO-1 and Occludin, immunofluorescence staining was performed. The deparaffinized jejunal sections were subjected to antigen retrieval in citrate buffer (pH 6.0) via a boiling-water bath for 15 min. After cooling and washing with PBS (5 min), the sections were blocked with 5% bovine serum albumin (BSA) for 30 min at room temperature. The sections were then incubated overnight at 4 °C with primary antibodies against Occludin (ABclonal, A12621) and ZO-1 (ABclonal, A0659) diluted in 1% BSA. Following washing with PBS, the sections were incubated with secondary antibodies for 50 min at room temperature in the dark. Nuclei were stained with DAPI (Servicebio, G1012) for 5 min. Slides were washed, mounted with antifade medium, and visualized via a fluorescence microscope (Nikon, Eclipse C1). The fluorescence signals of ZO-1 and Occludin were quantified as mean fluorescence intensity under identical exposure settings after background subtraction, based on five randomly selected non-overlapping fields per sample, using Image-Pro Plus 6.0 (Media Cybernetics, USA). Gene expression in jejunum and liver Total RNA was extracted from frozen jejunum and liver tissues via TRIzol reagent (Thermo Fisher Scientific, 15596026CN). The RNA quality was assessed via a NanoDrop 2000 spectrophotometer; an OD260/OD280 ratio between 1.8 and 2.0 was considered indicative of sufficient purity. cDNA was synthesized via a reverse transcription kit (Takara, RR047A). Specific primers for the target genes and the housekeeping gene β-actin (Table S2) were synthesized by Wuhan Servicebio Technology Co., Ltd. The 15 µL reaction volume consisted of 7.5 µL of SYBR Green Master Mix, 1.5 µL of primers (forward/reverse), 2 µL of cDNA, and 4.0 µL of RNase-free water. The PCR cycling conditions were 95 °C for 30 s, followed by 40 cycles of 95 °C for 15 s and 60 °C for 30 s. Western blotting analysis Frozen liver tissues were homogenized in RIPA lysis buffer (G2002, Servicebio, China) containing protease and phosphatase inhibitors. The total protein concentration was determined using a BCA protein assay kit (G2026, Servicebio, China). Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes. After blocking with 5% nonfat milk, the membranes were incubated overnight at 4 °C with primary antibodies against Nrf2 (GB113808, Servicebio, China), Keap1 (GB15847, Servicebio, China), CAT (GB11681, Servicebio, China), HO-1 (GB15104, Servicebio, China), NQO1 (GB15282, Servicebio, China), and GAPDH. After washing, the membranes were incubated with HRP-conjugated secondary antibodies. Protein bands were visualized using enhanced chemiluminescence reagents (G2020, Servicebio, China) and a chemiluminescence imaging system. Relative protein expression was quantified using ImageJ software and normalized to GAPDH. Jejunal microbiota 16S rRNA sequencing analysis Jejunal digesta samples from the CON and HCD2 groups (n = 6) were subjected to 16S rRNA sequencing. On the basis of our previous methods [14], genomic DNA was extracted via the MagPure Soil DNA LQ Kit (Magan). DNA concentration and purity were assessed via a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA) and agarose gel electrophoresis. The V3–V4 variable region of the bacterial 16S rRNA gene was amplified via the universal primers 343 F (5′-TACGGRAGGCAGCAG-3′) and 798R (5′-AGGGTATCTAATCCT-3′) [15]. Sequencing was performed on the Illumina NovaSeq 6000 platform to generate 250 bp paired-end reads. All sequencing was conducted by OE Biotech Co., Ltd. (Shanghai, China). Alpha and beta diversity analyses were performed via QIIME 2. Alpha diversity was assessed via the Chao1 and Shannon indices [16]. Beta diversity was evaluated via unweighted UniFrac distance matrices and visualized via unweighted UniFrac-based principal coordinate analysis (PCoA). Differential microbial taxa were identified via ANOVA, the Kruskal‒Wallis test, the t test, and the Wilcoxon rank‒sum test, as appropriate. Linear discriminant analysis effect size (LEfSe) was used to identify taxa with significantly different relative abundances between groups. Metabolomic analysis of liver tissue Nontargeted metabolomics analysis was performed on liver samples from the CON and HCD2 groups (n = 6). Metabolites were analyzed via a Thermo QE HF-X mass spectrometer coupled with an Ultimate 3000 UHPLC system (Dionex). The raw data were processed via Progenesis QI v3.0 (Nonlinear Dynamics, Newcastle, UK). Principal component analysis (PCA), orthogonal partial least squares-discriminant analysis (OPLS-DA), and pathway enrichment analysis were performed via MetaboAnalyst 5.0. Differential metabolites were identified on the basis of VIP > 1.0, FC > 2, and P < 0.05. Significant metabolites were subjected to hierarchical clustering via Cluster 3.0. Pathway enrichment maps were generated with reference to HMDB, the Kyoto Encyclopedia of Genes and Genomes (KEGG), and MetaboAnalyst 5.0 [17]. Proteomic analysis of liver tissue Proteomic profiling was performed on liver samples from the CON and HCD2 groups (n = 6) according to previously described methods. In brief, proteins were extracted via SDT lysis buffer (4% SDS, 100 mM Tris/HCl, pH 7.6, 0.1 M DTT), and the protein concentration was determined via the BCA assay. Appropriate amounts of protein from each sample were digested via the filter-aided sample preparation (FASP) method. The resulting peptides were desalted via C18 cartridges, lyophilized, reconstituted in 40 μL of dissolution buffer, and quantified according to the OD280. For each sample, 100 μg of peptide was labeled according to the manufacturer’s protocol for the Thermo Fisher TMT labeling kit. The labeled peptides were pooled and fractionated via an AKTA Purifier 100 system. Each fraction was separated via an easy-nLC nanoflow LC system and analyzed via Q Exactive mass spectrometry (Thermo Fisher Scientific). The raw spectra were processed in Proteome Discoverer 1.4 for protein identification and quantification. Target protein sets were annotated for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses via OmicsBean (http://www.omicsbean.cn/). Protein-protein interaction (PPI) networks were constructed via STRING (http://string-db.org/), and the interaction networks were visualized and analyzed accordingly. Statistical analysis All data were analyzed using one-way ANOVA in SPSS 23.0 (IBM Corp., Armonk, NY, USA). The statistical model was as follows: where Yij denotes the observed value of the dependent variable, μ represents the overall mean, Ti is the fixed effect of the treatment, and ϵij is the random residual error. When the overall treatment effect was significant, differences among means were further evaluated using Tukey’s multiple-comparison test. Orthogonal polynomial contrasts were additionally used to determine the linear and quadratic effects of increasing dietary supplementation levels of E. faecalis JM263. Results are presented as means ± SEM, and differences were considered significant at P < 0.05. Graphs were generated via GraphPad Prism 9.5.0 (GraphPad Software, San Diego, CA, USA). Results Freeze-dried preparation of E. faecalis JM263 To ensure stability during storage and facilitate administration, E. faecalis JM263 was microencapsulated with maltodextrin and lyophilized (Fig. 1). The colony morphology of the strain on MRS agar is shown in Fig. 1A; the colonies appeared circular with entire margins and smooth surfaces. Scanning electron microscopy (SEM) of the bacterial cells revealed an ovoid shape with a uniform size, tight arrangement, and smooth cell surface (Fig. 1B, C). Macroscopically, the resulting maltodextrin-encapsulated lyophilized product was a uniform, off-white powder with a loose texture (Fig. 1D). SEM analysis of the lyophilized powder (Fig. 1E, F) revealed that the particles were spherical with a dense surface structure. Notably, no significant bacterial leakage was observed on the surfaces of the particles. These results indicate that maltodextrin effectively encapsulates E. faecalis JM263, providing structural protection that increases its stability for storage and application as a feed additive. Characterization of maltodextrin-encapsulated lyophilized Enterococcus faecalis JM263 powder. A Colony morphology of E. faecalis JM263 on MRS agar. B, C Scanning electron microscopy (SEM) images of E. faecalis JM263 bacterial cells (magnification × 10,000 and × 40,000). D Macroscopic appearance of the lyophilized E. faecalis JM263 powder. E, F SEM images of the lyophilized powder particles (magnification × 100 and × 1000) E. faecalis JM263 enhances growth performance and systemic immunity in goats fed a high-concentrate diet As shown in Fig. 2, dietary supplementation with E. faecalis JM263 significantly affected growth performance in goats fed a high-concentrate diet. Compared with the CON group, the HCD2 group showed significantly higher FBW and ADG and a lower FCR (Fig. 2C–E; P < 0.05). Serum antioxidant capacity was also markedly enhanced by E. faecalis JM263 supplementation, as evidenced by increased SOD, T-AOC, GSH-Px, and CAT activities and decreased MDA concentration (Fig. 2G–K; P < 0.05). Among these variables, SOD, T-AOC, and GSH-Px showed significant linear and quadratic increases, CAT increased linearly, and MDA decreased both linearly and quadratically. Systemic immune status was likewise improved by E. faecalis JM263 supplementation. Serum IgA and IgG were significantly increased, whereas serum IL-6, IL-2, and TNF-α were significantly decreased, and IL-10 was significantly increased (Fig. 2L, N, P–S; P < 0.05). In addition, LPS concentrations in both serum and liver were significantly reduced by E. faecalis JM263 supplementation (Fig. 2T, U; P < 0.05). IgA and IgG showed significant linear and quadratic increases, IL-6 and TNF-α decreased both linearly and quadratically, IL-2 decreased linearly, IL-10 showed a significant quadratic response, and both serum and hepatic LPS showed significant linear and quadratic decreases. Overall, the HCD2 group generally exhibited the most favorable systemic responses. Effects of E. faecalis JM263 supplementation on growth performance and immune function in goats. A Schematic diagram of the experimental design. B Initial body weight (IBW). C Final body weight (FBW). D Average daily gain (ADG). E Feed conversion ratio (FCR). F Dry matter intake (DMI). G Superoxide dismutase (SOD). H Total antioxidant capacity (T-AOC). I Glutathione peroxidase (GSH-Px). J Catalase (CAT). K Malondialdehyde (MDA) content. L Immunoglobulin A (IgA). M Immunoglobulin M (IgM). N Immunoglobulin G (IgG). O Interleukin-1β (IL-1β). P Interleukin-6 (IL-6). Q Interleukin-2 (IL-2). R Interleukin-10 (IL-10). S Tumor necrosis factor-α (TNF-α). T Serum LPS. U Liver LPS. Data are presented as means ± SEM (n = 6). Different lowercase letters indicate significant differences among groups (P < 0.05) E. faecalis JM263 improves intestinal morphology in goats fed a high-concentrate diet As shown in Fig. 3, dietary supplementation with E. faecalis JM263 improved jejunal morphology and mucosal barrier-related parameters in goats fed a high-concentrate diet. Compared with the CON group, the HCD2 group showed significantly increased villus height, crypt depth, and villus height/crypt depth ratio (Fig. 3A, E–G; P < 0.05). Villus height showed significant linear and quadratic responses, whereas crypt depth increased linearly. PAS and AB-PAS staining further showed that E. faecalis JM263 supplementation enhanced mucosal barrier function, as reflected by increased goblet cell abundance and glycoprotein distribution (Fig. 3B, C, H, I). Both variables showed significant linear and quadratic responses, with the HCD2 group generally exhibiting the highest values (P < 0.05). In addition, the percentage of TUNEL-positive cells was significantly reduced in the HCD2 and HCD3 groups (Fig. 3D, J; P < 0.05), and the percentage of TUNEL-positive cells decreased linearly. Analysis of intestinal structural integrity in goats. A Histological structure of the jejunum (H&E staining; scale bars 100 and 20 μm). B PAS staining of jejunal tissue (scale bars 100 and 20 μm). C AB-PAS staining of jejunal tissue (scale bars 100 μm and 20 μm). D TUNEL staining of jejunal tissue (scale bars 100 μm and 20 μm). E Villus height. F Crypt depth. G Villus height/crypt depth ratio. H Number of goblet cells in the villi. I Distribution area of glycoproteins. J Percentage of TUNEL-positive cells. Data are presented as means ± SEM (n = 6). Different lowercase letters indicate significant differences among groups (P < 0.05) E. faecalis JM263 reinforces intestinal barrier function in goats fed a high-concentrate diet High-concentrate diet treatment compromised intestinal barrier function in goats; however, supplementation with E. faecalis JM263 effectively maintained barrier integrity (Fig. 4). Supplementation with E. faecalis JM263 in the HCD2 group significantly increased the relative fluorescence intensities and mRNA expression levels of ZO-1 and Occludin (Fig. 4B–G; P < 0.05). ZO-1 showed significant linear and quadratic responses, whereas Occludin increased linearly. In addition, Claudin mRNA expression was significantly upregulated in the HCD2 group (Fig. 4H; P < 0.05), showing both significant linear and quadratic responses. Jejunal inflammatory status was also markedly improved by E. faecalis JM263 supplementation. The mRNA expression levels of IL-1β, IL-6, TNF-α, and IFN-γ were significantly decreased (Fig. 4I–L; P < 0.05), whereas IL-10 was significantly increased (Fig. 4M; P < 0.05). Among these variables, IL-1β decreased linearly, IL-6, TNF-α, and IFN-γ decreased both linearly and quadratically, and IL-10 increased both linearly and quadratically. Overall, the HCD2 group generally exhibited the most pronounced improvement in jejunal barrier function and inflammatory status. Analysis of intestinal barrier function and inflammatory markers in goats. A Schematic diagram of the experimental workflow. B Immunofluorescence staining of ZO-1. C Immunofluorescence staining of Occludin. D Relative fluorescence intensity of Occludin. E Relative fluorescence intensity of ZO-1. F Relative ZO-1 mRNA expression. G Relative mRNA expression of Occludin. H Relative mRNA expression of Claudin. I Relative mRNA expression of IL-1β. J Relative mRNA expression of IL-6. K Relative mRNA expression of TNF-α. L Relative mRNA expression of IFN-γ. M Relative mRNA expression of IL-10. The fluorescence signals of ZO-1 and Occludin were quantified as mean fluorescence intensity under identical exposure settings after background subtraction, based on five randomly selected non-overlapping fields per sample. Data are presented as means ± SEM (n = 6). Different lowercase letters indicate significant differences among groups (P < 0.05) E. faecalis JM263 alleviates liver injury, inflammation, and oxidative stress in goats fed a high-concentrate diet High-concentrate diet feeding compromised hepatic health in goats, whereas supplementation with E. faecalis JM263 alleviated this injury (Fig. 5 and Fig. S1). Serum ALT and AST activities were significantly reduced by E. faecalis JM263 supplementation, with the HCD2 group showing the lowest values (Fig. 5B, C; P < 0.05). H&E staining revealed marked structural damage in the liver tissues of the CON and HCD1 groups, characterized by focal hepatocyte necrosis (red arrows), nuclear pyknosis, disordered cellular architecture, and mild lymphocytic infiltration (yellow arrows). In contrast, liver sections from the HCD2 and HCD3 groups showed improved morphology, with hepatocytes and hepatic sinusoids more regularly arranged around the central vein. However, mildly loose cellular arrangement and cytoplasmic pallor were still observed in a few hepatocytes (black arrows) (Fig. 5D), suggesting that E. faecalis JM263 mitigated, but did not completely prevent, HCD-associated hepatic injury. Hepatic inflammatory status was also improved by E. faecalis JM263 supplementation. The mRNA expression levels of IL-1β, IL-6, TNF-α, and IFN-γ were significantly decreased, whereas IL-10 was significantly increased in the HCD2 group (Fig. S1A–E; P < 0.05). Among these variables, IL-1β and IFN-γ decreased both linearly and quadratically, IL-6 and TNF-α decreased linearly, and IL-10 increased both linearly and quadratically. Oxidative stress-related pathways were also markedly modulated by E. faecalis JM263 supplementation. Hepatic Nrf2, CAT, GPX, SOD, NQO1, and HO-1 mRNA expression levels were significantly increased, whereas Keap1 was significantly decreased in the HCD2 group (Fig. 5F–L; P < 0.05). Nrf2, GPX, SOD, NQO1, and HO-1 showed significant linear increases, while Keap1 decreased linearly and quadratically. To further validate these findings at the protein level, Western blot analysis was performed (Fig. 5P). The protein expression of Nrf2, CAT, NQO1, and HO-1 was significantly increased, whereas Keap1 protein expression was significantly decreased in the HCD2 group (Fig. 5M–O, Q, R; P < 0.05), which was generally consistent with the mRNA expression patterns. In addition, hepatic apoptosis was attenuated by E. faecalis JM263 supplementation. As shown in Fig. S1, the mRNA expression levels of the proapoptotic genes Caspase-3, Caspase-8, Caspase-9, and Bax were significantly decreased, whereas the antiapoptotic gene Bcl-2 was significantly increased (Fig. S1F–J; P < 0.05). Among these variables, Caspase-3, Caspase-8, Caspase-9, and Bax decreased linearly, whereas Bcl-2 showed both significant linear and quadratic increases. Consistently, TUNEL staining revealed that the percentage of apoptotic cells was significantly reduced by E. faecalis JM263 supplementation (Fig. 5E; Fig. S1K; P < 0.05), with the lowest level observed in the HCD2 group. Analysis of hepatic function and health in goats (n = 6). A Schematic diagram of the experimental workflow. B Serum alanine aminotransferase (ALT) levels. C Serum aspartate aminotransferase (AST) levels. D Histopathological analysis of liver tissue (H&E staining; scale bars 100 μm and 20 μm). Red arrows indicate focal hepatocyte necrosis, yellow arrows indicate lymphocytic infiltration, and black arrows indicate residual mild hepatocellular abnormalities, including mildly loose cellular arrangement and cytoplasmic pallor. E TUNEL staining of liver tissue (scale bars: 100 μm and 20 μm). F Relative mRNA expression of Nrf2. G Relative mRNA expression of Keap1. H Relative mRNA expression of CAT. I Relative mRNA expression of GPX. J Relative mRNA expression of SOD. K Relative mRNA expression of HO-1. L Relative mRNA expression of NQO1. M Relative protein expression ratio of Nrf2/GAPDH. N Relative protein expression ratio of Keap1/GAPDH. O Relative protein expression ratio of CAT/GAPDH. P Representative Western blot bands of CAT, Keap1, Nrf2, HO-1, NQO1, and GAPDH. Q Relative protein expression ratio of HO-1/GAPDH. R Relative protein expression ratio of NQO1/GAPDH. Data are presented as means ± SEM. Different lowercase letters above the bars indicate significant differences among groups (P < 0.05) E. faecalis JM263 modulates the gut microbiota composition in goats fed a high-concentrate diet On the basis of the superior regulatory effects observed with the 0.5 g/kg HCD in previous assays, we selected the HCD2 group for 16S rRNA gene sequencing to investigate shifts in the gut microbiota. We identified 4,924 amplicon sequence variants (ASVs) in the CON group and 4951 ASVs in the HCD2 group, with 579 ASVs shared between the two groups (Fig. S2A). Alpha diversity analysis revealed no significant differences in community richness or diversity indices between the groups (Fig. S2B–E). However, distinct clustering in the microbial composition was observed between the dietary treatments, as indicated by NMDS and PCoA (Fig. 6A; Fig. S2F). At the phylum level, the community was dominated by Bacteroidota, Firmicutes, Proteobacteria, Actinobacteria, and Fusobacteriota (Fig. 6B; Fig. S2G). At the genus level, the predominant taxa included Muribaculaceae, Prevotella, Aeriscardovia, Bacteroides, and Lachnospiraceae_NK4A136_group (Fig. 6C; Fig. S2H). LEfSe identified Muribaculaceae and Acetatifactor as microbial biomarkers for the HCD2 group (LDA score > 3.5; Fig. 6D; Fig. S2I). Consistent with these findings, the relative abundances of Muribaculaceae and Acetatifactor were significantly greater in the HCD2 group than in the CON group (P < 0.05; Fig. 6E, F). To further elucidate the functional implications of these shifts, we performed Spearman correlation analysis between the enriched genera (Muribaculaceae and Acetatifactor) and key host parameters, including growth performance (ADG), liver function (ALT, AST), oxidative stress markers (SOD, GSH-Px, CAT, T-AOC, MDA), inflammatory cytokines (IL-2, IL-6, IL-10, TNF-α), barrier function proteins (ZO-1, Occludin, Claudin), and hepatic apoptotic and oxidative stress regulatory genes (Fig. 6G). The analysis revealed strong positive correlations between these bacteria and beneficial indicators, including ADG, antioxidant enzymes (SOD, GSH-Px, CAT, and T-AOC), the anti-inflammatory cytokine IL-10, barrier proteins (ZO-1, Occludin, and Claudin), the antiapoptotic gene Bcl-2, and hepatic antioxidant genes (Nrf2, SOD, GPX, and CAT). Conversely, negative correlations were observed with markers of injury and inflammation, including liver enzymes (ALT, AST), MDA, proinflammatory cytokines (IL-2, IL-6, and TNF-α), proapoptotic genes (caspase-3, caspase-8, caspase-9, and Bax), and Keap1. These findings suggest that the modulation of the gut microbiota—specifically the enrichment of Muribaculaceae and Acetatifactor—may play a pivotal role in the E. faecalis JM263-mediated improvement of gut‒liver health in goats fed high-concentrate diets. Diversity and composition of the goat gut microbiota (n = 6). A Nonmetric multidimensional scaling (NMDS) analysis based on Bray-Curtis distances. B Relative abundance of predominant bacteria at the phylum level. C Relative abundance of predominant bacteria at the genus level. D LEfSe analysis showing microbial biomarkers (LDA score distribution). E Relative abundance of Muribaculaceae. F Relative abundance of Acetatifactor. G Spearman correlation analysis between differentially abundant gut microbes and host phenotypic indices. * indicates P < 0.05 E. faecalis JM263 alters hepatic metabolic profiles in goats fed a high-concentrate diet Untargeted LC‒MS/MS metabolomics analysis identified a total of 4976 hepatic metabolites (Fig. S3A). PCA and hierarchical clustering heatmaps demonstrated a distinct separation of metabolic profiles between the CON and HCD2 groups, indicating significant metabolic reprogramming (Fig. 7A, B). To maximize group discrimination, an OPLS-DA model was constructed. The score plots clearly revealed segregation between the CON and HCD2 groups. The model quality parameters showed a high explanatory power (R2Y = 0.966). In addition, permutation testing yielded a Q2 intercept of −0.178, supporting that the model was not overfitted (Fig. S3B, C). On the basis of the screening criteria of VIP > 1, FC > 2, and P < 0.05, we identified 1,438 DEMs between the two groups. Among these, 472 metabolites were upregulated and 966 were downregulated in the HCD2 group compared with the CON group (Fig. 7C). KEGG pathway enrichment analysis revealed that arachidonic acid metabolism was a key pathway significantly modulated by E. faecalis JM263 (Fig. 7D, Table S3; P < 0.05). Specific analysis of metabolites within this pathway revealed distinct patterns. The relative abundances of PGA2 and TXB2-d4 were significantly lower in the HCD2 group than in the CON group (P < 0.05; Fig. 7H, I). Conversely, the relative abundance of 6-keto-PGF1alpha was significantly greater in the HCD2 group than in the CON group (P < 0.05, Fig. 7F). Furthermore, Troxilin B3 levels were significantly increased, whereas 12-keto-10,11,14,15-tetrahydro-LTB4 levels were significantly decreased in the HCD2 group compared with the control group (P < 0.05; Fig. 7E, G). Hepatic metabolomics analysis of goats (n = 6). A Principal component analysis (PCA) score plot. B Hierarchical clustering heatmap of differentially abundant metabolites. C Volcano plot of differentially accumulated metabolites (DEMs). D Bubble plot of the top 20 enriched KEGG pathways. E Relative abundance of troxilin B3. F Relative abundance of 6-keto-PGF1alpha. G Relative abundance of 12-keto-10,11,14,15-tetrahydro-LTB4. H Relative abundance of TXB2-d4. I Relative abundance of PGA2 E. faecalis JM263 alters the hepatic proteomic profile in goats fed a high-concentrate diet To provide a comprehensive understanding of the molecular alterations, we performed a proteomic analysis of liver tissues. A total of 5976 proteins and 46,523 peptides were identified (Fig. S4A), with the majority of peptide lengths ranging from 7 to 20 amino acids (Fig. S4B). PCA and hierarchical clustering revealed a distinct separation between the CON and HCD2 groups with no overlap, indicating significant proteomic shifts (Fig. 8A and Fig. S5). Using a threshold of FC > 2 and P < 0.05, we identified 379 differentially expressed proteins (DEPs). Among these proteins, 250 were upregulated and 129 were downregulated in the HCD2 group compared with the CON group (Fig. 8B). Gene Ontology (GO) annotation was employed to elucidate biological functions across biological processes (BP), cellular components (CC), and molecular functions (MF). As shown in Fig. 8C, BP analysis indicated that the DEPs were involved primarily in the innate immune response, defense response to bacteria, protein transport, immune response, and proteolysis. For CC, the DEPs were mainly localized to the membrane, cytosol, cytoplasm, nucleus, and plasma membrane. With respect to MF, the proteins presented functions such as iron ion binding, metal ion binding, heme binding, calcium ion binding, and ATP binding. Notably, consistent with our metabolomic findings, the arachidonic acid metabolism pathway was significantly enriched in the proteomic analysis (Fig. 8E, Table S4; P < 0.05). The expression patterns of proteins enriched in this pathway are visualized in a heatmap (Fig. 8D). Furthermore, GSEA confirmed the significant enrichment of the arachidonic acid metabolism gene set (Fig. 8F; P < 0.001). We further constructed a PPI network to evaluate the functional connectivity of the identified proteins (Fig. 8G). The analysis revealed that proteins associated with arachidonic acid metabolism (such as CYP2B6, CYP2J26, and CYP2C82) occupied central positions within the network. Additionally, IFIT2 emerged as a key hub node bridging arachidonic acid metabolism-related proteins with other metabolic pathways. These results further support the hypothesis that arachidonic acid metabolism acts as a critical metabolic pathway through which E. faecalis JM263 modulates hepatic health in goats fed high-concentrate diets. Hepatic proteomics analysis (n = 6). A Principal component analysis (PCA) score plot. B Volcano plot of differentially expressed proteins (DEPs). C Gene Ontology (GO) functional enrichment analysis (BP, CC, MF). D Heatmap of proteins enriched in the arachidonic acid metabolism pathway. E Bubble plot of the top 20 enriched KEGG pathways. F Gene set enrichment analysis (GSEA) of the arachidonic acid metabolism gene set. G Protein-protein interaction (PPI) network of hepatic DEPs Integrated correlation analysis linking gut microbiota, hepatic metabolites, and proteins with host phenotypes To establish a holistic regulatory network, we performed correlation analyses integrating the identified microbial biomarkers with the DEPs and DEMs involved in the hepatic arachidonic acid metabolism pathway. A correlation network was constructed to visualize these interactions (Fig. 9A). The results revealed robust correlations between the gut bacteria Muribaculaceae and Acetatifactor and specific hepatic metabolites and proteins. Notably, the metabolites TXB2-d4 and PGA2, along with the proteins CYP2B6, CYP2J26, and CYP2C82, occupied prominent node positions with high connectivity within the network. Furthermore, Mantel tests were employed to assess the correlations between these molecular signatures (microbial biomarkers, arachidonic acid-related proteins, and metabolites) and host phenotypic indices (Fig. 9B). Specifically, the analysis revealed strong correlations between the gut microbiota (Muribaculaceae and Acetatifactor) and host antioxidant and immune parameters. Moreover, hepatic metabolites (12-keto-10,11,14,15-tetrahydro-LTB4, PGA2,6-keto-PGF1alpha, TXB2-d4, and Troxilin B3) and proteins (ALOX15, CYP4A11, CYP2C88, CYP2C82, CYP2B4, CYP2J26, and CYP2B6) exhibited strong significant correlations with a wide range of phenotypic traits, including growth performance (ADG), liver function (ALT, AST), oxidative stress markers (SOD, GSH-Px, CAT, T-AOC, MDA), inflammatory cytokines (IL-2, IL-6, IL-10, TNF-α), intestinal barrier function (ZO-1, Occludin, Claudin), and hepatic apoptotic and oxidative stress regulatory genes (Caspase-3, Caspase-8, Caspase-9, Bax, Bcl-2, Nrf2, SOD, GPX, CAT, Keap1). Consistent with these findings, the targeted correlation heatmaps further showed that Muribaculaceae and Acetatifactor were negatively associated with proinflammatory arachidonic acid-related metabolites and proteins, while showing positive associations with protective metabolites, antioxidant-related proteins, and beneficial host phenotypes (Fig. S6). Collectively, these findings suggest a gut–liver axis-related mechanism in which E. faecalis JM263 was associated with enrichment of specific gut taxa and coordinated changes in hepatic proteomic and metabolic profiles related to arachidonic acid metabolism. These changes may contribute to the mitigation of subclinical health impairment induced by high-concentrate diets, thereby supporting improved growth and immune function in goats. Integrated multiomics correlation analysis. A Correlation network diagram illustrating the interactions between gut microbial biomarkers and the differentially abundant proteins and metabolites involved in hepatic arachidonic acid metabolism. B Mantel test analysis linking the gut microbiota, arachidonic acid-related hepatic metabolites, and proteins with host phenotypic indices Discussion In intensive ruminant production, while HCD offers short-term gains in growth performance, the ensuing accumulation of organic acids and depression of ruminal and intestinal pH precipitate the release of LPS. This cascade leads to compromised intestinal epithelial barrier integrity, systemic oxidative stress, and organ damage, posing significant challenges to the sustainable development of the goat industry [18]. E. faecalis, a facultative anaerobic, gram-positive lactic acid bacterium, is a ubiquitous commensal in the gastrointestinal tracts of humans and animals. It plays a pivotal role in maintaining gut microbiota homeostasis, modulating immune function, and synthesizing antimicrobial agents [19]. In the present study, we demonstrated that dietary supplementation with 0.5 g/kg E. faecalis JM263 significantly enhanced growth performance and health indices in goats challenged with an HCD. Notably, the beneficial effects of E. faecalis JM263 were not strictly dose-dependent, as the 0.5 g/kg supplementation level generally produced the most favorable responses, whereas the 1.0 g/kg level showed a slight decline in efficacy for several parameters. This pattern suggests a non-linear dose-response relationship, in which moderate supplementation confers maximal benefit, while further increasing the dose does not necessarily enhance the protective effect. One possible explanation is that excessive probiotic supplementation may impose an additional microbial load on the intestinal ecosystem, thereby partially disturbing host–microbe equilibrium or slightly reducing colonization efficiency of other beneficial taxa, as microbiome-based interventions are increasingly recognized to depend on ecological context, colonization dynamics, and microbial community interactions [20, 21]. Similar non-linear probiotic responses have been reported in other animal models, in which the recommended or intermediate dose was more effective than a higher dose and was associated with more favorable microbial or immune outcomes [22, 23]. In addition, although E. faecalis JM263 was overall beneficial in the present study, it cannot be excluded that an excessively high dose may alter host–microbe interactions or host responses to microbial signals, thereby attenuating part of its beneficial effect, given that host responses to microbial signals can vary according to the dose and timing of exposure [24]. Therefore, our findings suggest that 0.5 g/kg may represent a more appropriate supplementation level under the present experimental conditions, while the upper safety threshold and potential adverse effects of higher doses warrant further investigation. Systemic antioxidant capacity is intrinsically linked to overall host health. HCD feeding inevitably induces oxidative stress, precipitating detrimental alterations in growth, physiology, and metabolism that ultimately culminate in oxidative injury. In the present study, supplementation with E. faecalis JM263 significantly enhanced serum antioxidant defense mechanisms, as evidenced by increased activities of SOD, T-AOC, CAT, and GSH-Px, as well as reduced levels of MDA. This observed efficacy may be mechanistically attributed to the strain’s ability to scavenge DPPH and hydroxyl radicals, as demonstrated by our strain characterization [13]. These findings align with previous reports indicating a positive correlation between E. faecalis administration and increased host antioxidant capacity [25]. Immunoglobulins, ubiquitous serum glycoproteins with antibody activity, serve as critical biomarkers for evaluating humoral immunity. Concurrently, cytokine homeostasis is vital; pro-inflammatory cytokines (e.g., IL-1β, IL-6, and TNF-α) drive disease pathogenesis by modulating cell-mediated immunity, whereas anti-inflammatory cytokines (e.g., IL-10) maintain immune homeostasis by suppressing excessive inflammatory responses [26, 27]. Consequently, profiling immunoglobulins and cytokines provides essential insights into immune status and disease progression [28]. Previous studies have identified E. faecium as a promising functional feed candidate capable of increasing IgA levels and mitigating inflammation to increase growth performance in broilers [29]. Similarly, HCD feeding has been shown to incite systemic inflammation and compromise rumen health in goats, effects that can be alleviated by commercial probiotic supplementation [30]. Consistent with these findings, E. faecalis JM263 significantly attenuated the HCD-induced inflammatory response in the present study. We hypothesize that this immunomodulatory effect is inextricably linked to the strain’s ability to restore gut microbiota equilibrium and reinforce intestinal barrier function. Intestinal tissue injury, structural alterations, and oxidative stress synergistically compromise intestinal epithelial cell function, leading to reduced enzymatic secretion and, consequently, impeded nutrient digestion and absorption [31]. Therefore, maintaining intestinal integrity is fundamental to barrier function, immune responses, nutrient absorption, inflammation regulation, and microbial homeostasis, all of which collectively dictate overall health status [32]. It is well established that intestinal villus height is positively correlated with digestive and absorptive capacity [33]. In the present study, E. faecalis JM263 supplementation significantly increased jejunal villus height, the abundance of goblet cells and the area of glycoprotein distribution in HCD-fed goats. This enhancement not only expands the absorptive surface area and improves nutrient transport efficiency but also fortifies physical and chemical barriers by promoting mucus layer secretion [34]. This thickened mucosal barrier effectively reduces pathogen adhesion and the translocation of harmful metabolites, thereby ameliorating HCD-induced mucosal injury. Further TUNEL analysis confirmed that E. faecalis JM263 supplementation mitigated jejunal epithelial apoptosis in HCD-fed goats. By preventing excessive epithelial cell loss, the treatment maintained the structural continuity and functional stability of the intestinal mucosa [35]. To further characterize the regulatory effects of E. faecalis JM263 on the intestinal barrier, we assessed tight junction protein expression via immunofluorescence. Consistent with prior findings, E. faecalis JM263 upregulated the protein expression of ZO-1 and Occludin, findings that were corroborated by mRNA expression analysis [36, 37]. Additionally, regarding local immune regulation, E. faecalis JM263 supplementation significantly downregulated the mRNA expression of proinflammatory cytokines (IL-1β, IL-6, TNF-α, and IFN-γ) while increasing the expression of the anti-inflammatory cytokine IL-10 in the jejunum. These results suggest a dual mechanism in which E. faecalis JM263 not only alleviates intestinal injury through structural repair and barrier reinforcement but also effectively suppresses HCD-induced local inflammation by rebalancing the cytokine profile [38]. These findings underscore the critical role of E. faecalis JM263 in fortifying the intestinal barrier against HCD-induced stress. In the present study, the jejunum was selected as the representative intestinal segment because it is a major site of nutrient digestion and absorption and plays an important role in epithelial barrier function and mucosal immune regulation. Therefore, jejunal alterations are highly informative for evaluating gut barrier integrity under high-concentrate feeding conditions. Nevertheless, HCD may also affect other gastrointestinal segments, including the rumen, ileum, and colon. Thus, the conclusions regarding gut barrier function in the present study are limited primarily to the jejunum rather than the entire intestinal tract, and further segment-specific studies will be needed to determine whether similar effects occur throughout the gastrointestinal system. Accumulating evidence indicates that the gut and its microbiota interact with the liver through multiple mechanisms [39]. The normal function of this gut–liver axis relies heavily on the integrity of the intestinal barrier [40]. However, when barrier function is compromised or permeability increases, gut microbial metabolites and pathogen-associated molecular patterns (PAMPs) are translocated, disrupting internal homeostasis [41]. The proposed involvement of the gut–liver axis was further supported by the direct measurement of LPS. E. faecalis JM263 supplementation significantly reduced LPS concentrations in both serum and liver tissue, indicating a lower endotoxin burden and reduced hepatic exposure to gut-derived harmful substances. Together with the improvements in jejunal barrier integrity, these findings suggest that E. faecalis JM263 exerted a protective effect against HCD-associated liver injury, at least partly through the gut–liver axis, rather than demonstrating full restoration to a normal healthy baseline. Consistent with this interpretation, E. faecalis JM263 supplementation decreased the serum activities of ALT and AST, suggesting an attenuation of HCD-associated hepatic dysfunction [27]. Consistent with our serum and intestinal findings, E. faecalis JM263 modulated hepatic inflammatory status by downregulating the mRNA expression of proinflammatory cytokines. This observation supports the hypothesis that increased intestinal permeability exacerbates the influx of harmful substances into the circulation, aggravating systemic inflammation [42], a process effectively mitigated by the barrier-reinforcing properties of E. faecalis JM263 [43]. To further characterize HCD-induced hepatic injury, we performed TUNEL staining. Consistent with the expression of core apoptosis-related genes, E. faecalis JM263 supplementation downregulated the expression of proapoptotic genes (caspase-3, caspase-8, caspase-9, and Bax) and maintained the Bcl-2/Bax balance. This effectively blocks the activation of both the mitochondrial and extrinsic apoptotic pathways, thereby suppressing excessive hepatocyte apoptosis [44]. Interestingly, our validation of the Nrf2/Keap1 signaling pathway revealed significantly increased mRNA expression of Nrf2, SOD, GPX, CAT, NQO1, and HO-1 and downregulated Keap1 expression in liver tissues. These results indicate that E. faecalis JM263 enhances hepatic antioxidant defense capabilities by activating the Nrf2/Keap1 pathway, as further supported by the increased expression of the downstream antioxidant targets NQO1 and HO-1, thereby alleviating HCD-induced oxidative stress injury [45]. In summary, E. faecalis JM263 mitigates HCD-induced systemic injury in goats by synergistically improving intestinal function, balancing inflammatory responses, inhibiting apoptosis, and enhancing antioxidant capacity via the gut–liver axis. Emerging research highlights the crosstalk between the microbiota and hepatocytes as a fundamental pathway within the gut–liver axis [46]. Indeed, gut dysbiosis has been closely implicated in the etiology of chronic metabolic disorders, including obesity, nonalcoholic fatty liver disease (NAFLD), and cirrhosis [47]. In the present study, E. faecalis JM263 mitigated the detrimental impact of HCD on the intestinal barrier and was associated with an increased abundance of the family Muribaculaceae and the genus Acetatifactor. Among these taxa, Muribaculaceae has been increasingly recognized as a saccharolytic gut bacterial family with broad polysaccharide-utilizing capacity and short-chain fatty acid (SCFA)-producing potential, and its enrichment has frequently been associated with improved mucosal barrier integrity and attenuated inflammatory responses [48]. Recent studies further suggest that Muribaculaceae-related bacteria may contribute to host health through microbiota-dependent metabolic functions, including SCFA production and protection against intestinal pathogen colonization [49, 50]. By contrast, the functional role of Acetatifactor remains less well defined and may be context-dependent. Although Acetatifactor is an anaerobic gut commensal associated with acetate-related metabolism, current evidence does not establish it as a core beneficial probiotic taxon [51, 52]. Importantly, we did not find direct evidence that either Muribaculaceae or Acetatifactor specifically synthesizes or degrades the arachidonic acid-derived metabolites identified in the present study. Therefore, in our dataset, these taxa should be interpreted primarily as microbial correlates of improved gut ecological status and barrier/immune function, which may indirectly influence host arachidonic acid metabolism through microbiota-host signaling rather than direct production or catabolism of these lipid mediators. We postulate that these shifts in microbial composition, together with the associated alterations of the metabolic milieu, may contribute to changes in hepatic health via the gut–liver axis. Proteomics precisely captures the abundance and posttranslational modification status of functional executors, thereby clarifying the core regulators of inflammation, apoptosis, and oxidative stress pathways [53]. Similarly, metabolomics provides a direct readout of the terminal metabolic phenotype, revealing alterations in the metabolite profile associated with hepatic physiological and pathological states [54]. To elucidate the molecular basis underlying the protective effects of E. faecalis JM263 via the gut–liver axis, we performed an integrated analysis of hepatic proteomics and metabolomics data to systematically elucidate the regulatory mechanisms mitigating HCD-induced liver injury. Notably, both the differentially abundant proteins and the differentially abundant metabolites were significantly enriched in the arachidonic acid metabolism pathway. Further validation via GSEA and PPI networks supported the involvement of arachidonic acid metabolism as a key pathway associated with the hepatic effects of E. faecalis JM263 in HCD-fed goats. Key metabolic enzymes, including CYP2B6, CYP2J26, and CYP2C82, exhibited differential expression patterns. As core regulators of arachidonic acid metabolism, these cytochrome P450 family proteins dictate metabolic flux and conversion efficiency toward distinct bioactive derivatives [55]. Crucially, the metabolic profile shifted toward a more anti-inflammatory state following E. faecalis JM263 supplementation, particularly in the HCD2 group. Pro-inflammatory metabolites, such as PGA2, TXB2-d4, and 12-keto-10,11,14,15-tetrahydro-LTB4, were significantly downregulated, whereas anti-inflammatory or protective metabolites, including 6-keto-PGF1α and Troxilin B3, were significantly upregulated. PGA2, a classical pro-inflammatory prostaglandin, was downregulated, likely reducing the release of hepatic inflammatory cytokines and dampening the inflammatory signaling cascade [56]. Similarly, a reduction in TXB2-d4 contributes to alleviating hepatic microcirculatory disturbances and inflammatory injury [57]. Furthermore, 12-keto-10,11,14,15-tetrahydro-LTB4, a downstream metabolite generated during the catabolic inactivation of leukotriene B4 (LTB4), was significantly downregulated in the HCD2 group [58]. Because LTB4 is a well-established pro-inflammatory lipid mediator, the reduction of this downstream leukotriene-related metabolite in the present study is more appropriately interpreted as being consistent with altered inflammatory lipid signaling rather than as evidence that 12-keto-10,11,14,15-tetrahydro-LTB4 itself exerts a direct hepatoprotective effect [59, 60]. Conversely, Troxilin B3, an arachidonic acid-derived trioxilin, was significantly increased. Trioxilins are lipid mediators within the hepoxilin/trioxilin family and have been implicated in inflammatory regulation, and TrXB3 has been reported to exhibit potential partial agonistic activity toward PPARγ [61, 62]. However, the direct functional relevance of Troxilin B3 in goat liver health remains unclear. Therefore, the observed changes in 12-keto-10,11,14,15-tetrahydro-LTB4 and Troxilin B3 should be regarded primarily as hypothesis-generating observations that support the involvement of arachidonic acid metabolism, rather than as definitive evidence that these individual metabolites act as specific effector mediators of hepatic protection. It should be noted that these arachidonic acid-related metabolites are primarily host-derived lipid mediators rather than products directly synthesized by the gut microbiota. Therefore, the role of E. faecalis JM263 and the altered microbial taxa in the present study is more likely to involve modulation of host metabolic machinery and microbiota-host signaling interactions than direct microbial production of these eicosanoid derivatives. Notably, the regulation of arachidonic acid metabolism involves tight synergistic crosstalk with the Nrf2/Keap1 antioxidant pathway. Following E. faecalis JM263 supplementation, coordinated changes in the Nrf2/Keap1 pathway were associated with reduced oxidative stress under HCD conditions, which may in turn contribute to the suppression of proinflammatory branches of host arachidonic acid metabolism. Conversely, changes in certain arachidonic acid-derived metabolites, including 6-keto-PGF1α and Troxilin B3, may also be linked to a more favorable hepatic redox and inflammatory state, although the specific functional relevance of Troxilin B3 remains to be established. This concerted action collectively inhibits the expression of proapoptotic genes (caspase-3, caspase-8, caspase-9, and Bax) and preserves the Bcl-2/Bax equilibrium, thereby blocking the activation of hepatocellular apoptotic pathways [63]. Crucially, correlation analysis revealed close associations between Muribaculaceae and Acetatifactor and the differential proteins (e.g., CYP2B6, CYP2J26), metabolites (e.g., PGA2, 6-keto-PGF1α), and host phenotypic indices (growth, liver function, immunity, and antioxidant status). These findings indicate that E. faecalis JM263 was associated with enrichment of Muribaculaceae and Acetatifactor, which in turn was closely linked to changes in hepatic proteins, metabolites, and host phenotypes. This microbial shift may contribute to gut–liver axis-related regulation and is associated with coordinated changes in host Nrf2/Keap1 signaling and host arachidonic acid metabolism. This coordinated response may contribute to the downregulation of proinflammatory enzymes and metabolites alongside the upregulation of protective counterparts, ultimately suppressing hepatic inflammation and apoptosis, enhancing antioxidant capacity, and improving overall liver function and host health. Collectively, these results support an association-based mechanistic framework in which E. faecalis JM263 is associated with gut microbial shifts, coordinated changes in host Nrf2/Keap1 signaling and host arachidonic acid metabolism, and improved host phenotypes, but they do not establish direct causality. One limitation of the present study is that a healthy low-concentrate control group was not included. Thus, although the present design allowed evaluation of the protective or mitigating effects of E. faecalis JM263 under high-concentrate challenge conditions, it did not permit full assessment of the absolute magnitude of HCD-induced pathology or the extent of recovery toward a normal baseline. Accordingly, the observed benefits should be interpreted primarily as attenuation of injury under HCD challenge rather than definitive restoration to a healthy physiological state. Future studies including a low-concentrate, high-roughage control group are warranted. In addition, no formal a priori power analysis was performed in the present study. Nevertheless, several principal phenotypic endpoints showed large effect sizes in the present dataset, and the main metabolomic and proteomic comparisons also exhibited clear between-group separation, supporting the overall robustness of the principal signals despite the absence of formal post-hoc power analysis for the high-dimensional omics datasets. Future studies with larger cohorts and prospective power calculations will be valuable, particularly for omics datasets with relatively high biological variability. In addition, although the integrated microbiota, metabolomic, and proteomic analyses revealed consistent and biologically meaningful associations, the present multiomics integration remains primarily correlative. Therefore, the direct causal roles of specific taxa such as Muribaculaceae and Acetatifactor in driving hepatic arachidonic acid metabolism and host phenotypic improvement could not be determined in the current study. Future studies incorporating fecal microbiota transplantation, gnotobiotic animal models, or targeted microbial intervention strategies will be important for establishing causality more directly. Nevertheless, comprehensive safety evaluations of E. faecalis JM263, including whole-genome characterization, broader screening of virulence-associated determinants, and assessment of antibiotic resistance transferability, are still ongoing and remain necessary before this strain can be considered for commercial application. Conclusion In summary, our findings demonstrate that E. faecalis JM263 supplementation effectively mitigates the deleterious effects of a high-concentrate diet (HCD) in goats, thereby increasing body weight gain, antioxidant capacity, and immune function while optimizing intestinal barrier function. Furthermore, integrated microbiota, proteomic, and metabolomic analyses suggest that the beneficial effects of E. faecalis JM263 are associated with enrichment of specific gut taxa and coordinated changes in the Nrf2/Keap1 pathway and arachidonic acid metabolism, ultimately alleviating intestinal and hepatic inflammation via the gut–liver axis (Fig. 10). These findings support the potential of E. faecalis JM263 as a promising functional feed additive for improving ruminant health in intensive production systems, while further causality-oriented studies will be needed to validate the specific microbiota-dependent mechanisms involved. Schematic diagram of the regulatory network for E. faecalis JM263-mediated attenuation of oxidative stress and the systemic inflammatory response Supplementary Information Additional file 1: Table S1. Composition and nutrient levels of high-concentrate diet (%, dry matter basis). Table S2. Primers for quantitative real-time PCR. Figure S1. Effects of E. faecalis JM263 supplementation on hepatic inflammatory and apoptosis-related markers in goats fed a high-concentrate diet. (A) Relative mRNA expression of IL-1β. (B) Relative mRNA expression of IL-6. (C) Relative mRNA expression of TNF-α. (D) Relative mRNA expression of IFN-γ. (E) Relative mRNA expression of IL-10. (F) Relative mRNA expression of Caspase-3. (G) Relative mRNA expression of Caspase-8. (H) Relative mRNA expression of Caspase-9. (I) Relative mRNA expression of Bax. (J) Relative mRNA expression of Bcl-2. (K) Percentage of TUNEL-positive cells in the liver. Data are presented as means ± SEM. Different lowercase letters above the bars indicate significant differences among groups (P < 0.05). Figure S2. Intestinal microbial diversity of goats. (A) Venn diagram of ASV distribution. (B) ACE index. (C) Chao1 index. (D) Shannon index. (E) Simpson index. (F) PCoA analysis. (G) Dominant microorganisms at the phylum level (TOP 15). (H) Dominant microorganisms at the genus level (TOP 15). (I) Annotated branch diagram of differential species. Figure S3. Results of goat-liver metabolomics. (A) Statistical summary of metabolite quantities at different levels. (B) OPLS-DA score plot. (C) Permutation test of the OPLS-DA model. Figure S4. Results of goat-liver proteomics. (A) Statistical chart of protein and peptide identification. (B) Peptide-length distribution chart. Figure S5. Hierarchical clustering heatmap of all quantified proteins. Figure S6. Correlation heatmaps showing the associations of Muribaculaceae and Acetatifactor with arachidonic acid-related metabolites, proteins, and host phenotypic indices. (A) Spearman-correlation heatmap between the two key gut microbial taxa and hepatic arachidonic acid-related metabolites. (B) Spearman-correlation heatmap between the two key gut microbial taxa and arachidonic acid-related hepatic proteins. (C) Spearman-correlation heatmap between the two key gut microbial taxa and host phenotypic indices. Color intensity represents the Spearman-correlation coefficient. Red indicates positive correlations, and green indicates negative correlations. Asterisks indicate significant correlations (P < 0.05). Additional file 2: Table S3. Differential metabolites enriched in arachidonic acid metabolism. Table S4. Differential proteins enriched in arachidonic acid metabolism. Acknowledgements Not applicable. Authors’ contributions XZ. Designed the research, Methodology, Conceptualization, Investigation, and Writing of the original draft. AKhan and WX. Conceptualization, Investigation, Data curation. XS. Conceptualization, Supervision, Funding acquisition, Project administration, Writing - Review & editing. All the authors reviewed the manuscript. All the authors read and approved the final manuscript. Funding This work was supported by the National Natural Science Foundation of China (42171060), the Innovation Development Supporting Plan Project of Key Industries in Southern Xinjiang (2021DB014) and the Modern Agricultural Industry Technology System in China (CARS-38). Data availability The original sequence data provided in the study have been deposited in the National Center for Biotechnology Information Sequence Red Archive under accession number PRJNA1372469. The metabolomics data have been deposited to MetaboLights repository with the study identifier MTBLS13688. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (https://proteomecentral.proteomexchange.org) via the iProX partner repository with the dataset identifier PXD072919. Declarations Ethics approval and consent to participate The institutional committee of Southwest University of Science and Technology provided ethical permission (reference number L2025004), and compliance with applicable national or international laws and regulations was also needed. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Additional file 1: Table S1. Composition and nutrient levels of high-concentrate diet (%, dry matter basis). Table S2. Primers for quantitative real-time PCR. Figure S1. Effects of E. faecalis JM263 supplementation on hepatic inflammatory and apoptosis-related markers in goats fed a high-concentrate diet. (A) Relative mRNA expression of IL-1β. (B) Relative mRNA expression of IL-6. (C) Relative mRNA expression of TNF-α. (D) Relative mRNA expression of IFN-γ. (E) Relative mRNA expression of IL-10. (F) Relative mRNA expression of Caspase-3. (G) Relative mRNA expression of Caspase-8. (H) Relative mRNA expression of Caspase-9. (I) Relative mRNA expression of Bax. (J) Relative mRNA expression of Bcl-2. (K) Percentage of TUNEL-positive cells in the liver. Data are presented as means ± SEM. Different lowercase letters above the bars indicate significant differences among groups (P < 0.05). Figure S2. Intestinal microbial diversity of goats. (A) Venn diagram of ASV distribution. (B) ACE index. (C) Chao1 index. (D) Shannon index. (E) Simpson index. (F) PCoA analysis. (G) Dominant microorganisms at the phylum level (TOP 15). (H) Dominant microorganisms at the genus level (TOP 15). (I) Annotated branch diagram of differential species. Figure S3. Results of goat-liver metabolomics. (A) Statistical summary of metabolite quantities at different levels. (B) OPLS-DA score plot. (C) Permutation test of the OPLS-DA model. Figure S4. Results of goat-liver proteomics. (A) Statistical chart of protein and peptide identification. (B) Peptide-length distribution chart. Figure S5. Hierarchical clustering heatmap of all quantified proteins. Figure S6. Correlation heatmaps showing the associations of Muribaculaceae and Acetatifactor with arachidonic acid-related metabolites, proteins, and host phenotypic indices. (A) Spearman-correlation heatmap between the two key gut microbial taxa and hepatic arachidonic acid-related metabolites. (B) Spearman-correlation heatmap between the two key gut microbial taxa and arachidonic acid-related hepatic proteins. (C) Spearman-correlation heatmap between the two key gut microbial taxa and host phenotypic indices. Color intensity represents the Spearman-correlation coefficient. Red indicates positive correlations, and green indicates negative correlations. Asterisks indicate significant correlations (P < 0.05). Additional file 2: Table S3. Differential metabolites enriched in arachidonic acid metabolism. Table S4. Differential proteins enriched in arachidonic acid metabolism. Data Availability Statement The original sequence data provided in the study have been deposited in the National Center for Biotechnology Information Sequence Red Archive under accession number PRJNA1372469. The metabolomics data have been deposited to MetaboLights repository with the study identifier MTBLS13688. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (https://proteomecentral.proteomexchange.org) via the iProX partner repository with the dataset identifier PXD072919.